Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals
about
Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemiaExpansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection.T-Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus.CD28 pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death
P2860
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@ast
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@en
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@nl
type
label
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@ast
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@en
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@nl
prefLabel
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@ast
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@en
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@nl
P2093
P2860
P3181
P1433
P1476
Acyclovir Therapy Reduces the ...... n Immune Competent Individuals
@en
P2093
Annette Pachnio
Ashini Fox
Jusnara Begum
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0125287
P407
P577
2015-01-01T00:00:00Z